GATC Health Releases Video Presentation on its Novel Fentanyl Addiction Treatment Delivered at Opioid Settlement Abatement Summit

DATE

Feb 16, 2023

CATEGORY

Company

Introduction by Dr. Stephen Loyd, expert in opioid use disorder treatment and named an Advocate for Action by the Office of National Drug Control Policy (ONDCP), an office of the President of the United States.IRVINE, Calif., February 16, 2023 — GATC Health Corp, an artificial intelligence (AI) company revolutionizing drug discovery and disease prediction, today released the video of its presentation on the company’s drug candidate to treat fentanyl addiction which was given at the recent Opioid Addiction Abatement Settlement Summit. GATC’s Chief Operating Officer, Tyrone Lam, presented for the company with a passionate introduction by Dr. Stephen Loyd, who’s story is featured in the Hulu series, “Dopesick,” portrayed by Michael Keaton’s character.

View video: https://www.youtube.com/watch?v=T4nbxu87LLw

Over 300 attendees participated in The Opioid Settlement Abatement Summit – Model Guidance for States, Counties, Municipalities and Tribes  on Thursday, January 26, 2023 at Georgetown University and virtually. The event focused on providing model abatement guidance for states, counties, municipalities and tribes to effectively plan for, implement and track opioid settlement funds. The event highlighted effective programs, initiatives and tools that are easily adopted and should be considered in state abatement plans as funding begins to come in.

Mr. Lam’s talk was introduced by Dr. Stephen Loyd, an Internal Medicine/Addiction Medicine physician who graduated medical school and residency from the James H. Quillen College of Medicine at East Tennessee State University. He currently serves as the Vice-President of the Tennessee Board of Medical Examiners. Dr. Loyd was the Assistant Commissioner (Opioid Czar) for Substance Abuse Services in the Tennessee Department of Mental Health and Substance Abuse Services in Governor Bill Haslam’s administration. He has served as an expert witness in more than twenty federal and state cases against physicians who were improperly prescribing controlled substances. Dr. Loyd was named an Advocate for Action by the Office of National Drug Control Policy (ONDCP), an office of the President of the United States. He has delivered over five hundred educational lectures on addiction and treatment of opioid use disorder and proper prescribing of controlled substances.

Dr. Loyd was an original member (still active) of the Treatment of Chronic Pain Guidelines Committee which defined pain treatment for providers in the state of Tennessee. He has worked as an Addiction Medicine Physician in both the inpatient and outpatient settings, specializing in the treatment of opioid dependent pregnant women. Dr. Loyd has served on multiple drug courts in Tennessee and remains an active participant in drug court in the 4th Judicial District under Judge Duane Slone. Aside from his work directly in the field of the opioid use disorder treatment, Dr. Loyd’s story has been featured in Hulu series, “Dopesick,” portrayed by Michael Keaton’s character, Samuel Finix as well as the best-selling book, Dopesick, written by Beth Macy.

Dr. Loyd currently holds positions as the Chief Medical Officer for Cedar Recovery, the Medical Director for Recepto, the Chair of the Tennessee Opioid Abatement Council appointed by current Tennessee Governor Bill Lee. Dr. Loyd has been in recovery from opioid and benzodiazepine addiction since July 8, 2004.

The video is made available by Addiction Abatement, Inc. and the January 26, 2023, Opioid Addiction Abatement Settlement Summit held at Georgetown University.

About GATC Health

GATC Health Corp is a science and technology company revolutionizing disease prediction and drug discovery and development through its transformative AI platform and approach, which de-risks drug pipelines and accelerates new therapies to treat disease with accuracy, efficiency and speed never before achieved in medical science. The company’s validated and proprietary Multiomics Advanced Technology™ (MAT) platform simulates human biochemistry’s billions of interactions for accurate and rapid disease prediction, novel target identification, and drug discovery and development. GATC envisions the future of medicine now, where health is protected, disease is reversed, and every person’s unique biology is treated with precision.

GATC is accelerating the future of predictive, individualized medicine, today.

Contacts

Join Us in Transforming
Healthcare Through Advanced AI

We're always on the lookout for like-minded partners committed to making healthcare better, more efficient, and safer. Reach out today to see how our specialized AI solutions can be tailored to your needs.

© 2024 GATC Health Corp. All rights reserved.